1,629 Shares in Intuitive Surgical, Inc. $ISRG Acquired by Win Advisors Inc.

Win Advisors Inc. acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 1,629 shares of the medical equipment provider’s stock, valued at approximately $923,000.

Several other institutional investors have also recently modified their holdings of ISRG. Brighton Jones LLC raised its position in shares of Intuitive Surgical by 24.9% during the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after purchasing an additional 731 shares during the last quarter. Sivia Capital Partners LLC raised its holdings in Intuitive Surgical by 3.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after acquiring an additional 34 shares during the last quarter. Schnieders Capital Management LLC. raised its holdings in Intuitive Surgical by 38.0% in the 2nd quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after acquiring an additional 268 shares during the last quarter. Osterweis Capital Management Inc. acquired a new position in Intuitive Surgical in the 2nd quarter valued at $200,000. Finally, Main Street Financial Solutions LLC raised its holdings in Intuitive Surgical by 92.4% in the 2nd quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after acquiring an additional 1,407 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several analyst reports. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Sanford C. Bernstein boosted their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an “outperform” rating in a report on Friday, January 23rd. JPMorgan Chase & Co. cut their price target on Intuitive Surgical from $625.00 to $550.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Finally, Zacks Research cut shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Monday, March 30th. Eighteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $581.91.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Several recent articles argue that Intuitive Surgical’s competitive moat is strengthening, with bullish commentary calling it a potential long-term “forever” stock. Intuitive Surgical’s Moat Is Getting Stronger — Is This the Closest Thing to a ‘Forever’ Stock?
• Positive Sentiment: Zacks highlighted ISRG as a solid growth stock, pointing to above-average financial growth and continued outperformance potential. Looking for a Growth Stock? 3 Reasons Why Intuitive Surgical (ISRG) is a Solid Choice
• Positive Sentiment: Analyst sentiment remains broadly favorable, with multiple firms maintaining Buy/Outperform ratings and a consensus price target well above the current trading range. Intuitive Surgical stock details and analyst ratings
• Neutral Sentiment: CEO/EVP Gary Loeb sold 400 shares in a pre-arranged Rule 10b5-1 plan. The sale was disclosed to the SEC, but it appears routine rather than a fresh negative signal. Intuitive Surgical (NASDAQ:ISRG) EVP Gary Loeb Sells 400 Shares
• Negative Sentiment: Shares remain weighed down by safety and regulatory concerns, including the FDA’s Class I recall classification for SureForm stapler reloads, which raises the risk of serious procedural complications. Intuitive Surgical slides as investors weigh Class I stapler-reload recall and lingering safety overhang
• Negative Sentiment: Market chatter also points to institutional selling and a wave of insider sales, which may be adding to bearish sentiment around ISRG. Intuitive Surgical (ISRG) Stock Plunges to 52-Week Low Amid Institutional Exodus

Intuitive Surgical Trading Down 6.7%

Shares of Intuitive Surgical stock opened at $420.06 on Tuesday. The company has a fifty day moving average price of $469.33 and a 200 day moving average price of $517.03. Intuitive Surgical, Inc. has a twelve month low of $417.74 and a twelve month high of $603.88. The stock has a market cap of $148.77 billion, a price-to-earnings ratio of 50.92, a price-to-earnings-growth ratio of 3.59 and a beta of 1.51.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The firm had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same period in the prior year, the company earned $1.81 EPS. The firm’s revenue was up 23.0% on a year-over-year basis. Analysts forecast that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Activity

In related news, SVP Patricia L. Wadors sold 220 shares of the company’s stock in a transaction on Friday, February 27th. The shares were sold at an average price of $499.71, for a total transaction of $109,936.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark Brosius sold 645 shares of the company’s stock in a transaction on Monday, March 9th. The stock was sold at an average price of $485.01, for a total transaction of $312,831.45. Following the sale, the senior vice president directly owned 1,613 shares of the company’s stock, valued at approximately $782,321.13. This trade represents a 28.57% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 6,201 shares of company stock worth $3,034,567 in the last quarter. Insiders own 0.60% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.